首页> 外文期刊>Journal of Surgical Oncology >Does histology predict outcome for malignant vascular tumors of the liver?
【24h】

Does histology predict outcome for malignant vascular tumors of the liver?

机译:组织学是否可以预测肝恶性血管肿瘤的预后?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and Objectives Malignant vascular tumors (MVT) of the liver are uncommon and poorly understood. We hypothesized that tumor histology is a predominant factor associated with survival in these tumors. Methods Patients with malignant histopathologic diagnoses of hepatic angiosarcoma (AS), hemangioendothelioma (HE) and its epithelioid variant (EHE), or hemangiopericytoma (HP) were identified using the SEER database (1973-2007). Overall survival (OS) was studied with Kaplan-Meier curves. Results We included 297 patients with MVT (207 AS, 28 HE, 56 EHE, 6 HP). All tumors demonstrated metastatic potential, although EHE and AS had the highest rate of regional or distant metastases (75% each). Patients with AS had the shortest median OS (1 month), however, those undergoing surgery had improved survival (6 months). Three patients with AS underwent liver transplant and lived for 11, 21, and 91 months each. Patients with EHE had the longest overall median survival of 75 months (30-183, P < 0.001). Surgical resection and transplant did not demonstrate an improvement in OS of patients with EHE in multivariable models. Conclusions Histology is an important factor in determining survival for patients with hepatic MVT. Patients with EHE have the longest OS, whereas patients with AS have shorter survival but may benefit from surgery.
机译:背景与目的肝脏恶性血管肿瘤(MVT)罕见,了解甚少。我们假设肿瘤组织学是与这些肿瘤的存活相关的主要因素。方法使用SEER数据库(1973- 2007年)对肝血管肉瘤(AS),血管内皮瘤(HE)及其上皮样变体(EHE)或血管周皮细胞瘤(HP)的组织病理学诊断为恶性。使用Kaplan-Meier曲线研究了总生存期(OS)。结果我们纳入了297例MVT患者(207 AS,28 HE,56 EHE,6 HP)。尽管EHE和AS具有最高的区域或远处转移率(各为75%),但所有肿瘤均具有转移潜力。 AS患者的中位OS最短(1个月),但是接受手术的患者生存期有所改善(6个月)。 3例AS患者接受了肝移植,每个分别存活11、21和91个月。 EHE患者的总体中位生存期最长,为75个月(30-183,P <0.001)。在多变量模型中,手术切除和移植并未显示EHE患者的OS改善。结论组织学是决定肝MVT患者生存率的重要因素。 EHE患者的OS最长,而AS患者的生存期较短,但可以从手术中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号